Pharma Leaders

APRIL 17, 2023

Abliva is a clinical-stage company developing medicines to treat rare and severe primary mitochondrial diseases. NV354 has indicated to be safe and efficacious in pre-clinical models, with regard to optimal pharmacological properties, including high levels of brain penetration.

FDA 52

FDA Pharmacology Medicine Leads 52

European Pharmaceutical Review

JULY 4, 2024

2 Approach taken by regulators in the UK The Medicines and Healthcare products Regulatory Agency regulates herbal medicines in the UK. Herbal medicines placed on the market since April 2011 must have either a traditional herbal registration (THR) or a Marketing Authorisation (MA). 2012/1916). 2012/1916). 2012/1916). 2012/1916).

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

pharmaphorum

NOVEMBER 1, 2022

Investigating the next generation of genetic medicine through RNA based therapies. RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious, and chronic diseases. Heads of Translational Medicine. Website: [link].

Medicine 52

Medicine Pharmacology Networking Pharma 52

Impetus Digital

AUGUST 2, 2024

Personalized Medicine AI can help develop precision medicine by analyzing patient data , including demographic, clinical, and genetic information, as well as information about their metabolism and microbes, environmental exposures, and lifestyle factors, to predict how different patients will respond to various therapies.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

European Pharmaceutical Review

MARCH 11, 2024

HIV treatment and prevention are at an inflection point after years of continuously improving the standard of care of once-daily oral medicines. Our industry is on the cusp of the next wave of medicines that will guide the coming decade of HIV care, making HIV a smaller part of people’s lives. 3 But that paradigm is rapidly changing.

Medicine 98

Medicine Pharmacology Healthcare Healthcare 98

European Pharmaceutical Review

JULY 27, 2023

Cardiovascular diseases are the leading cause of death globally with over 18.5 Cardiovascular diseases are the leading cause of death globally with over 18.5 Meta‑analyses of these trials have shown that the therapy is safe and can lead to a reduction in incidences of death and recurrent myocardial infarction. to 1 percent).

Pharmacology 98

Pharmacology Manufacturing Leads Patients 98

European Pharmaceutical Review

MAY 2, 2023

Cancer remains a global threat with around 10 million people dying from the disease each year worldwide, making it the second leading cause of death. 3 With greater scientific understanding of cancer, the industry has made significant progress in developing innovative medicines to help patients. 1,2 In the EU, an estimated 2.7

Patients 105

Patients Medicine Marketing Medical 105

Pharmaceutical Technology

NOVEMBER 3, 2022

This is due to aging populations around the world, which leads to an increased risk of such conditions, explains Craig Beavers, PhD, assistant professor at the University of Kentucky’s College of Pharmacy in Lexington. There needs to be more investment into local production to improve the availability of these medicines, says Page.

Medicine 111

Medicine Manufacturing Pharmacology Healthcare 111

Legacy MEDSearch

JUNE 15, 2023

Cala , the bioelectronic medicine leader setting a new standard of care for chronic disease, today announced the commercial launch of its next generation system: the Cala kIQ System, the first and only FDA-cleared wearable device that delivers effective therapy for action hand tremor relief in people with essential tremor and Parkinson’s disease.

Patients 98

Patients Recruitment Pharmacology Management 98

pharmaphorum

JANUARY 16, 2023

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. And all are predominantly prevented or treated with medicines that are decades old.

FDA 88

FDA Healthcare Healthcare Medicine 88

European Pharmaceutical Review

JULY 25, 2024

This progress underscores the potential of gene therapy to revolutionise medicine by addressing the root causes of genetic disorders. Roger ‘s work has involved leading the strategy and build of UCB’s global gene therapy research platform and digital transformation in global research.

Pharmacology 52

Pharmacology Manufacturing Medicine Training 52

pharmaphorum

JANUARY 26, 2023

A 2022 study from the Royal College of Physicians and British Pharmacological Society demonstrated the potential of pharmacogenomics, with scientists identifying the genetic cause behind an individual’s drug response for over forty medicines. Just one mutation can lead to a complete change in protein formation.

Pharmacology 120

Pharmacology Government Leads Physicians 120

Pharmaceutical Technology

FEBRUARY 8, 2023

Blank acknowledged that in many cases, an exclusively paediatric patient population could lead to difficulties with drawing consent for early phase trials. Still, Blank suggested that companies enroll the patient population that is most likely to benefit, because early phase studies contain the most safety risks.

FDA 105

FDA Patients Pharmacology Pharmaceutical 105

European Pharmaceutical Review

JULY 18, 2024

The potential to target more than one tumour antigen is interesting, as are the possible advantages for the patients receiving these investigational medicines. She leads Ipsen’s Early Development Portfolio across the company’s three therapeutic focus areas (Oncology, Rare Disease and Neuroscience).

Food and Drug Administration 59

Food and Drug Administration Engineering Pharmacology Side effects 59

Pharmaceutical Technology

FEBRUARY 13, 2023

Key considerations in the candidate selection stage The first step in a drug development program is choosing the optimum molecule from a range of potential leads that have been optimized within drug discovery. We start by using in-silico modeling of any pre-existing data associated with the lead compounds.

Food and Drug Administration 52

Food and Drug Administration Leads Pharmaceutical Pharmaceutical research 52

European Pharmaceutical Review

SEPTEMBER 22, 2023

Targeting toxic species of Abeta, such as multimers (with aducanumab and lecanemab) or pyroglutamate Abeta3-42 (with donanemab), induced significant removal of Abeta plaque load in the brains of Alzheimer’s patients, leading to the delay in cognitive decline. Treatment with the mAbs delayed cognitive decline by 2.6 months for lecanemab and 5.5

Food and Drug Administration 97

Food and Drug Administration Safety Patients Leads 97

Quantified

JUNE 28, 2022

The reality is that leading companies are looking for ways to drive impact that go beyond optimizing reach and frequency. To do this, they will not only need new knowledge but a substantially better ability to engage, connect and influence the HCP, leading to more meaningful interactions and increased conversion.

Sales 52

Sales Pharma Training Management 52

Pharmaceutical Representative Training

JUNE 22, 2024

Technological advancements, shifting market dynamics, and updated regulations are leading to significant changes within the pharmaceutical industry. The DOJ’s investigation revealed that the company misled HCPs and patients about the risks associated with the opioid, leading to overprescription and abuse.

Sales 52

Sales Pharmaceutical Ethics Pharmaceutical Sales 52

European Pharmaceutical Review

JULY 13, 2023

This could lead to significant research waste. 5 When these medicines are prescribed to patients, we can use feedback from the real-world data that documents clinical outcomes, efficacy measures, patient-reported outcomes, and adverse events. Expert Review of Clinical Pharmacology. British journal of pharmacology.

Medical 98

Medical Food and Drug Administration Pharmacology Medicine 98

Contrarian Sales Techniques

DECEMBER 5, 2023

Another game-changer has been the shift towards personalized medicine. This could mean staying updated with the latest industry trends, enrolling in advanced sales training programs, or pursuing further education in areas like business management or pharmacology. Embracing a mindset of lifelong learning keeps you agile and adaptable.

Pharmaceutical Sales 52

Pharmaceutical Sales Training Sales Pharmaceutical 52

Pharmaceutical Technology

AUGUST 8, 2022

You want to use it to show what is working well, or tell ‘if you’re struggling in this situation, I want to identify the trigger,’” says Dr. Jose Castillo-Mancilla, associate professor, School of Medicine, University of Colorado, Anschutz. But the pharmacology to quantify adherence also depends on race, gender, weight, and other factors.

Food and Drug Administration 122

Food and Drug Administration FDA Medicine Patients 122

Pharmaceutical Technology

FEBRUARY 17, 2023

Most drugs being developed now are more tailored to specific mechanisms of action compared to past drugs, says Dr. Gareth Veal, PhD, a professor of cancer pharmacology at Newcastle University. Ratain says achieving the right dosage requires an understanding of clinical pharmacology and a randomised trial.

FDA 115

FDA Side effects Pharmacology Patients 115

Pharmaceutical Technology

JUNE 15, 2023

Entering into select, high-value collaborations allows us to efficiently deploy our platform together with leading companies while we continue to build out our own pipeline of innovative and impactful medicines.”

Pharmacology 52

Pharmacology Medicine Sales Leads 52